Trans Genic Balance Sheet Health
Financial Health criteria checks 3/6
Trans Genic has a total shareholder equity of ¥6.0B and total debt of ¥2.2B, which brings its debt-to-equity ratio to 37%. Its total assets and total liabilities are ¥9.8B and ¥3.8B respectively. Trans Genic's EBIT is ¥102.0M making its interest coverage ratio 2.2. It has cash and short-term investments of ¥2.5B.
Key information
37.0%
Debt to equity ratio
JP¥2.22b
Debt
Interest coverage ratio | 2.2x |
Cash | JP¥2.48b |
Equity | JP¥6.00b |
Total liabilities | JP¥3.81b |
Total assets | JP¥9.81b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 2342's short term assets (¥6.5B) exceed its short term liabilities (¥2.4B).
Long Term Liabilities: 2342's short term assets (¥6.5B) exceed its long term liabilities (¥1.4B).
Debt to Equity History and Analysis
Debt Level: 2342 has more cash than its total debt.
Reducing Debt: 2342's debt to equity ratio has increased from 11.1% to 37% over the past 5 years.
Debt Coverage: 2342's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 2342's interest payments on its debt are not well covered by EBIT (2.2x coverage).